March 12, 2014
The state of New Jersey has joined a $22 million settlement to resolve former Genzyme Corp. employees' False Claims Act allegations in Florida federal court that the company marketed its Seprafilm adhesion barrier for unapproved uses, Acting Attorney General John J. Hoffman said Wednesday.
May 03, 2012
A Florida federal judge on Thursday tossed two whistleblower False Claims Act suits brought by former Genzyme Corp. employees and a doctor accusing the company of improperly marketing its Seprafilm adhesion barrier, after the federal government said the parties had reached a proposed settlement.